Clinical Trial Update: OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study) [Phase 3]

View source ↗

Summary

Phase 3 Blossom Study comparing Obinutuzumab against cyclophosphamide plus glucocorticoids for primary membranous nephropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Obinutuzumab (obinutuzumab)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Huashan Hospital | Conditions: Primary Membranous Nephropathy | Phase 3 | Status: RECRUITING